Arrowhead Pharmaceuticals, Inc. (ARWR)

NASDAQ: ARWR · Real-Time Price · USD

60.73

-2.02 (-3.22%)

At close: Oct 12, 2026, 4:00 PM EDT

60.75

+0.02 (0.03%)

After-hours: Oct 12, 2026, 7:30 PM EDT

Arrowhead Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 12, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Capitalization	8,578	4,769	2,408	2,880	3,498	6,509
Market Cap Growth	67.97%	98.03%	-16.40%	-17.67%	-46.25%	47.77%
Enterprise Value	8,360	4,588	2,436	2,799	3,183	6,017
Last Close Price	60.73	34.49	19.37	26.87	33.05	62.43

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 12, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Forward PE	-	140.94	140.94	140.94	140.94	140.94
PS Ratio	12.81	5.75	678.12	11.96	14.38	47.07
PB Ratio	18.41	9.47	12.60	10.03	8.36	15.92
P/TBV Ratio	18.65	10.39	13.61	11.03	9.05	16.47
P/FCF Ratio	-	30.40	-	-	-	44.06
P/OCF Ratio	-	26.56	-	-	-	37.99

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 12, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
EV/Sales Ratio	12.49	5.53	686.02	11.63	13.09	43.51
EV/EBITDA Ratio	-	37.52	-	-	-	-
EV/EBIT Ratio	-	46.65	-	-	-	-
EV/FCF Ratio	-	29.25	-	-	-	40.72

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 12, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Debt / Equity Ratio	2.96	1.48	4.46	1.34	0.20	0.06
Debt / EBITDA Ratio	-	5.36	-	-	-	-
Debt / FCF Ratio	-	4.74	-	-	-	0.17
Net Debt / Equity Ratio	-0.47	-0.34	0.91	-0.04	-0.69	-0.84
Net Debt / EBITDA Ratio	1.09	-1.42	-0.30	0.06	1.71	2.43
Net Debt / FCF Ratio	2.91	-1.11	-0.29	0.04	1.52	-2.32
Asset Turnover	0.38	0.66	0.00	0.33	0.35	0.22
Quick Ratio	5.71	4.73	6.57	3.75	2.67	2.58
Current Ratio	5.90	4.86	6.74	3.95	2.92	2.63
Return on Equity (ROE)	-55.21%	8.67%	-254.98%	-59.33%	-42.68%	-32.36%
Return on Assets (ROA)	-8.10%	4.87%	-39.43%	-17.58%	-15.91%	-15.11%
Return on Invested Capital (ROIC)	-101.07%	16.53%	-187.71%	-101.05%	-180.86%	-127.38%
Return on Capital Employed (ROCE)	-12.40%	8.30%	-58.00%	-31.10%	-32.30%	-26.40%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 12, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Earnings Yield	-3.73%	-0.03%	-24.90%	-7.13%	-5.03%	-2.16%
FCF Yield	-0.88%	3.29%	-25.10%	-11.48%	-5.40%	2.27%
Buyback Yield / Dilution	-7.74%	-11.67%	-12.21%	-1.26%	-1.62%	-3.00%

SEC Filings: 10-K · 10-Q